» Articles » PMID: 18955782

Association of Abdominal Obesity with Atherosclerosis in Type 2 Diabetes Mellitus (T2DM) in Korea

Overview
Specialty General Medicine
Date 2008 Oct 29
PMID 18955782
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate the relationship between obesity, insulin resistance and atherosclerosis in type 2 diabetes mellitus (T2DM) patients. Total 530 patients with T2DM were included. To evaluate the severity of atherosclerosis, we measured the coronary artery calcification (CAC) score, intima-media thickness (IMT) of the common carotid artery, and the ankle-brachial pressure index (ABPI). Subjects were classified according to body mass index (BMI), a marker of general obesity, and waist-to-hip ratio (WHR), a marker of regional obesity. The insulin sensitivity index (ISI) was measured by the short insulin tolerance test. All subjects were classified into four groups, according to BMI: the under-weight group, the normal-weight (NW) group, the over-weight (OW) group, and the obese (OB) group. WHR and systolic blood pressure, triglycerides (TG), HDL-cholesterol (HDLC), free fatty acids (FFA), fibrinogen, and fasting c-peptide levels were significantly different between BMI groups. TG, HDL-C, FFA, fibrinogen and ISI were significantly different between patients with and without abdominal obesity. In the OW group as well as in the NW group, carotid IMT, ABPI and CAC score were significantly different between patients with and without abdominal obesity. This study indicates that abdominal obesity was associated with atherosclerosis in T2DM patients.

Citing Articles

Plasma Atrial Natriuretic Peptide Predicts Oxidized Low-Density Lipoprotein Levels in Type 2 Diabetes Mellitus Patients Independent of Circulating Adipokine and Cytokine.

Bakillah A, Al Subaiee M, Soliman A, Obeid K, Bashir S, Al Hussaini A Int J Mol Sci. 2025; 26(5).

PMID: 40076485 PMC: 11899485. DOI: 10.3390/ijms26051859.


Body composition reference values in Singaporean adults using dual-energy X-ray absorptiometry-The Yishun study.

Soh B, Lee S, Wong W, Pang B, Lau L, Jabbar K PLoS One. 2022; 17(10):e0276434.

PMID: 36269751 PMC: 9586348. DOI: 10.1371/journal.pone.0276434.


Epigallocatechin-3-gallate ameliorates glucolipid metabolism and oxidative stress in type 2 diabetic rats.

Li W, Zhu C, Liu T, Zhang W, Liu X, Li P Diab Vasc Dis Res. 2020; 17(6):1479164120966998.

PMID: 33280417 PMC: 7919214. DOI: 10.1177/1479164120966998.


MicroRNA-219 decreases hippocampal long-term potentiation inhibition and hippocampal neuronal cell apoptosis in type 2 diabetes mellitus mice by suppressing the NMDAR signaling pathway.

Zhang L, Chen Z, Yang S, Shaer M, Wang Y, Dong J CNS Neurosci Ther. 2018; 25(1):69-77.

PMID: 29804319 PMC: 6436581. DOI: 10.1111/cns.12981.


Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes.

Lachine N, Elnekiedy A, Megallaa M, Khalil G, Sadaka M, Rohoma K Ther Adv Endocrinol Metab. 2016; 7(2):47-56.

PMID: 27092230 PMC: 4821001. DOI: 10.1177/2042018816637312.


References
1.
Jones C, Pei D, Staris P, Polonsky K, Chen Y, Reaven G . Alterations in the glucose-stimulated insulin secretory dose-response curve and in insulin clearance in nondiabetic insulin-resistant individuals. J Clin Endocrinol Metab. 1997; 82(6):1834-8. DOI: 10.1210/jcem.82.6.3979. View

2.
Kannel W, DAWBER T, Kagan A, REVOTSKIE N, Stokes 3rd J . Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med. 1961; 55:33-50. DOI: 10.7326/0003-4819-55-1-33. View

3.
Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S . The metabolically obese, normal-weight individual revisited. Diabetes. 1998; 47(5):699-713. DOI: 10.2337/diabetes.47.5.699. View

4.
ARAD Y, Spadaro L, Goodman K, Newstein D, Guerci A . Prediction of coronary events with electron beam computed tomography. J Am Coll Cardiol. 2000; 36(4):1253-60. DOI: 10.1016/s0735-1097(00)00872-x. View

5.
. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. 2001; 894:i-xii, 1-253. View